Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections
NCT00305227Phase 2Completed
- Sponsor
- University of Washington
- Start
- Mar 2006
- Primary completion
- Apr 2012
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus crispatus ctv-05 in urinary tract infection (UTI), sponsored by University of Washington. Started Mar 2006; status: completed.
02
Drugs
lactobacillus crispatus ctv-05
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT00305227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305227.